Experience the Future of Connectivity: Ribbon Unveils Revolutionary Compact Modular Sled with 400ZR and 800ZR Ports in Live Demo

Demo of 800G ZR+ with interoperable PCS showcases Ribbon’s innovative transport solutions Introduction Ribbon Communications Inc. recently made waves in the telecommunications industry with the demonstration of a cutting-edge solution supporting 400G ZR+ with the ability to upgrade to 800G ZR+ on a single sled. This breakthrough, showcased at NGON / NetworkX, highlights Ribbon’s commitment…

Read More

Get the Scoop: Our Fun and Relatable Take on Buying Back Our Own Shares!

Endeavour Announces Transaction in Own Shares London, 08 October 2024 Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 07 October 2024 Aggregate number of ordinary shares of USD 0.01 each purchased:…

Read More

Breaking News: Class Action Lawsuit Filed Against Iris Energy Limited – Investors Encouraged to Take Action, Says Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Announces Lawsuit Against Iris Energy Limited Introduction On October 07, 2024, Bragar Eagel & Squire, P.C., a renowned stockholder rights law firm, revealed that a class action lawsuit has been filed against Iris Energy Limited (“Iris Energy” or the “Company”) (NASDAQ: IREN). The lawsuit was filed in the United States…

Read More

Attention Investors: Take the Lead in the Webtoon Entertainment Inc. Securities Lawsuit!

Investor Alert: Deadline Approaching for WEBTOON Entertainment Inc. IPO Lawsuit New York, Oct. 7, 2024 – Rosen Law Firm, a global investor rights law firm, is reminding purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) about the upcoming lead plaintiff deadline on November 4, 2024. This deadline is related to the Company’s initial…

Read More

Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib: A Third-Generation EGFR TKI for Lung Cancer Treatment

Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib: A Third-Generation EGFR TKI for Lung Cancer Treatment Description SAN FRANCISCO and SUZHOU, China , Oct. 7, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic,…

Read More

Get Ready to Dive into Nuburu Inc.’s Exciting Future: Liqueous LP Unveils $65 Million Financing Program with Limited Dilution!

Welcome to the Future of Financing A New Standard for Growth Capital Breaking Boundaries with Nuburu Inc. and Liqueous LP It’s not every day that we see a groundbreaking partnership like the one between Liqueous LP and Nuburu Inc. This collaboration is not just about financing – it’s about setting a new industry standard, leveraging…

Read More

Calling All Verv Investors: Time to Take the Lead in Verve Therapeutics’ Securities Fraud Lawsuit!

Investor Alert: Important Deadline Approaching for Verve Therapeutics Securities Class Action What You Need to Know Hey there, savvy investor! Have you heard about the latest news regarding Verve Therapeutics, Inc. securities? If not, let me bring you up to speed. The Rosen Law Firm, a well-known global investor rights law firm, is reminding purchasers…

Read More